financetom
Business
financetom
/
Business
/
illumin Appoints Brian Garrigan as Chief Revenue Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
illumin Appoints Brian Garrigan as Chief Revenue Officer
Oct 15, 2025 5:57 AM

08:32 AM EDT, 10/15/2025 (MT Newswires) -- illumin Holdings (ILLM.TO), an advertising technology company, said Wednesday it has appointed Brian Garrigan as chief revenue officer effective immediately. He will report to illumin's chief executive Simon Cairns.

Garrigan was most recently senior vice president of sales at Simpli.fi. In his new role, he will focus on expanding illumin's reach across North America, Latin America, and Europe while strengthening client relationships and revenue performance.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fiera Capital Q3 revenue slightly misses estimates
Fiera Capital Q3 revenue slightly misses estimates
Nov 13, 2025
Overview * Fiera Capital ( FRRPF ) Q3 revenue slightly misses analyst expectations * Adjusted EPS for Q3 meets analyst estimates * Company achieved positive net organic growth in AUM, driven by new relationships Outlook * Company did not provide specific guidance for future quarters or full year Result Drivers * NET ORGANIC GROWTH - Positive net organic growth of...
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
Nov 13, 2025
07:43 AM EST, 11/13/2025 (MT Newswires) -- HLS Therapeutics ( HLTRF ) said Thursday that third-quarter net loss narrowed slightly as revenue rose. Net loss improved to US$3.92 million, or $0.12 per share, from a loss of $4.84 million, or $0.15 per share in the prior year period. Revenue decreased 4% to $13.5 million, primarily due to lower Clozaril Canada...
BrainsWay Receives FDA Clearance for Adolescent Depression Treatment
BrainsWay Receives FDA Clearance for Adolescent Depression Treatment
Nov 13, 2025
07:01 AM EST, 11/13/2025 (MT Newswires) -- BrainsWay ( BWAY ) said Thursday it received US Food and Drug Administration clearance to offer its deep transcranial magnetic stimulation as an add-on treatment for major depressive disorder in patients aged 15 to 21. The therapy uses magnetic pulses to stimulate brain areas tied to mood and is intended to be used...
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Nov 13, 2025
Overview * Palatin fiscal Q1 2026 revenue rises to $8.8 mln, driven by Boehringer Ingelheim agreement * Company reports fiscal Q1 net income of $4.7 mln, reversing a loss from last year * Palatin ( PTN ) completes $18.2 mln public offering, regains NYSE American compliance Outlook * Company plans IND submission and Phase 1 trial for PL7737 in first...
Copyright 2023-2026 - www.financetom.com All Rights Reserved